Market open
$
43.11
Change
-1.77 -3.94%
Volume
Volume 56,241
Jan 30, 2023, 10:06 a.m.
Real time quotes
Previous close
$ 44.88
$ 43.11
Change
-1.77 -3.94%
Day low
Day high
$42.15
$44.20

52 week low
52 week high
$20.98
$61.29

Market cap
$4.43B
Average volume
692,763
P/E ratio
N/A
Rev. per Employee
$100,774
EPS
-6.20
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ZLAB
-
The SEC Wants to Delist Chinese Stocks. What That Means for China Funds.
- Barron's Online
-
The Bond Market Has Shifted. A Hawkish Surprise May Be Coming.
- Barron's Online
-
Why Alibaba and Other Chinese Stocks Could Face More Delisting Threats
- Barron's Online
-
NIO, Chinese EV Stocks Are Falling Again. Here Are Two Reasons.
- Barron's Online
-
Yes, Inflation Could Get Even Worse, at a Bad Time for the Fed
- Barron's Online
-
Alibaba and Other Chinese Stocks Got Crushed Thursday. Here's Why.
- Barron's Online
-
14 Beaten-Down Pandemic Plays to Watch
- Barron's Online
-
Don’t Rush to Buy Chinese Stocks Right Now. Here’s Why.
- Barron's Online
-
Incyte enters license deal with Zai Lab for commercialization of Incyte's cancer treatment in China
- Tomi Kilgore
-
Zai Lab stock price target cut to $33 from $43 at Leerink
- Tomi Kilgore
-
Zai Lab upgraded to overweight from neutral at J.P. Morgan
- Tomi Kilgore
-
Zai Lab started at outperform with $42 stock price target at Leerink
- Tomi Kilgore
-
Zai Lab started at neutral with $32 stock price target at J.P. Morgan
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For October 16, 2017
- Benzinga.com
Other News on ZLAB
-
Zai Lab Limited (ZLAB) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
Zai Lab appoints Zentalis' exec as chief scientific officer
- Seeking Alpha
-
Why China Stocks Are Surging This Week
- Zacks.com
-
Deal Activity Could Jumpstart Biotechnology
- Seeking Alpha
-
Warning: ZLAB is at high risk of performing badly
- Seeking Alpha
-
SEC Warns Chinese Companies About Risks of Auditor Changes
- The Wall Street Journal Interactive Edition
-
Warning: ZLAB is at high risk of performing badly
- Seeking Alpha
-
Baron New Asia Fund Q2 2022 Shareholder Letter
- Seeking Alpha
-
Zai Lab Limited 2022 Q2 - Results - Earnings Call Presentation
- Seeking Alpha
-
Tracking Baillie Gifford's 13F Portfolio - Q2 2022 Update
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
- Loading more headlines...
Press Releases on ZLAB
-
Zai Lab Appoints Michel Vounatsos To Its Board of Directors
- GlobeNewswire
-
Zai Lab Announces Participation in January Investor Conferences
- GlobeNewswire
-
Tuesday's ETF Movers: MCHI, PPH
- MarketNewsVideo.com
-
Zai Lab Announces Participation in November Investor Conferences
- GlobeNewswire
-
Zai Lab Launches its first Trust Report
- GlobeNewswire
-
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
- Financial News Media
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com